Biodesix Inc (BDSX) stock

BDSXNasdaqServices-Medical LaboratoriesFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 4/30

$9.88+0.09 (+0.92%)

Close on Nov 13, 2026Market cap $104.25MP/E –Yield –

Biodesix total assets

Total assets on the balance sheet at the end of each period.

Biodesix's total assets was $93.94M at Sep 30, 2026. For fiscal 2025 it was $87.48M, down 10.0% from the year before. The highest annual figure on record is $121.07M in fiscal 2020.

Annual total assets

Period	Period end	Value	Change
FY2025	Dec 31, 2025	$87.48M	-10.0%
FY2024	Dec 31, 2024	$97.24M	-1.9%
FY2023	Dec 31, 2023	$99.10M	+6.7%
FY2022	Dec 31, 2022	$92.91M	+22.1%
FY2021	Dec 31, 2021	$76.10M	-37.1%
FY2020	Dec 31, 2020	$121.07M	+168.8%
FY2019	Dec 31, 2019	$45.03M	–

Quarterly total assets

Change is against the same quarter a year earlier.

Period	Period end	Value	Change
Q3 FY2026	Sep 30, 2026	$93.94M	+5.9%
Q2 FY2026	Jun 30, 2026	$95.33M	+8.6%
Q1 FY2026	Mar 31, 2026	$94.64M	+9.7%
Q4 FY2025	Dec 31, 2025	$87.48M	-10.0%
Q3 FY2025	Sep 30, 2025	$88.72M	-13.6%
Q2 FY2025	Jun 30, 2025	$87.74M	-24.3%
Q1 FY2025	Mar 31, 2025	$86.24M	-1.1%
Q4 FY2024	Dec 31, 2024	$97.24M	-1.9%
Q3 FY2024	Sep 30, 2024	$102.74M	+18.4%
Q2 FY2024	Jun 30, 2024	$115.84M	+49.2%
Q1 FY2024	Mar 31, 2024	$87.20M	+7.9%
Q4 FY2023	Dec 31, 2023	$99.10M	+6.7%
Q3 FY2023	Sep 30, 2023	$86.79M	+37.3%
Q2 FY2023	Jun 30, 2023	$77.62M	+3.2%
Q1 FY2023	Mar 31, 2023	$80.79M	+31.0%
Q4 FY2022	Dec 31, 2022	$92.91M	+22.1%
Q3 FY2022	Sep 30, 2022	$63.20M	-29.8%
Q2 FY2022	Jun 30, 2022	$75.23M	-26.1%
Q1 FY2022	Mar 31, 2022	$61.65M	-46.6%
Q4 FY2021	Dec 31, 2021	$76.10M	-37.1%
Q3 FY2021	Sep 30, 2021	$90.00M	+93.3%
Q2 FY2021	Jun 30, 2021	$101.80M	+126.1%
Q1 FY2021	Mar 31, 2021	$115.49M	–
Q4 FY2020	Dec 31, 2020	$121.07M	–
Q3 FY2020	Sep 30, 2020	$46.55M	–
Q4 FY2019	Dec 31, 2019	$45.03M	–